Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Laboratory testing stories

Oct 30, 2026

PinkDx vaginal swab test could detect endometrial cancer without painful biopsy

A new vaginal swab test developed by molecular diagnostics company PinkDx may help women with abnormal bleeding detect endometrial cancer without undergoing a painful biopsy. The development comes as death rates from endometrial cancer, one of the most common cancers in women, are increasing.

Oct 30, 2026·5 sources
00
Oct 29, 2026

Major international studies identify accurate non-invasive tests for metabolic liver disease

Two major international studies have delivered the strongest evidence to date on which non-invasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH, potentially reducing reliance on liver biopsy.

Oct 29, 2026·3 sources
00
Oct 23, 2026

Standard kidney function tests underestimate chronic kidney disease in cancer patients, study finds

New research presented at ASN Kidney Week 2026 reveals that commonly used measures of kidney function underestimate the prevalence of chronic kidney disease in patients with cancer. The study compared measured glomerular filtration in 1,200 adults with solid tumors.

Oct 23, 2026·2 sources
00
Oct 22, 2026

Quest Diagnostics reports cyberattack affecting patient records

Quest Diagnostics disclosed unauthorized access to its Quanum Lab Services Manager system, which is used by healthcare professionals to order tests and view lab results, potentially exposing patient records.

Oct 22, 2026·4 sources
00
Jul 18, 2026

FDA retracts cyclospora finding in Taylor Farms lettuce as false positive

The FDA apologized and confirmed that laboratory results showing cyclospora parasite in Taylor Farms lettuce samples were false positives after re-testing, as investigation into the outbreak affecting over 5,000 cases continues.

Jul 18, 2026·4 sources
00

Top claims

  • ▪The PinkDx clinical trial aims for the vaginal swab test to detect at least 90% of endometrial cancers while correctly ruling out cancer in at least half of non-cancer cases.
  • ▪Standard endometrial cancer diagnostics rely on transvaginal ultrasounds to measure uterine lining thickness and tissue biopsies to identify cancerous or precancerous cells.
  • ▪Endometrial cancer death rates and annual case diagnoses in the United States are increasing, driven in part by a rising prevalence of aggressive disease forms.

Subtopics

Diagnostic medicine3Cancer & Oncology2Chronic disease2Drug Policy, Pricing & Approval2Biomarkers & bloodwork testing1Cancer1Cancer and Cancer Treatment1Cancer diagnosis1Clinical genomics1Clinical trials1Cybersecurity1Cyclosporiasis outbreak1Data privacy1Diagnostic imaging1Drug Approval and Clinical Trials1Early cancer detection1Electronic health records1Healthcare cybersecurity1Healthcare industry1Infectious Disease and Outbreaks1Laboratory data1Medical imaging1Medical records privacy1Medical research1

Related timelines

Crypto hacks

100 stories

Payments

118 stories

Congress

110 stories

Ebola outbreak

85 stories

Iran War

209 stories